体外冲击波疗法治疗胫骨应力性骨折疗效分析

目的观察体外冲击波在胫骨应力性骨折患者的疗效,并观察体外冲击波治疗的安全性。方法对2011年1月至2012年9月在我院治疗的34例胫骨应力性骨折患者,随机分为试验组(19例)和对照组(15例)。试验组使用体外冲击波对骨折处进行干预。对照组采用石膏固定的方法治疗。治疗后每4周复查X片、CT,并检查全身状况、进行DOMS疲劳程度6级及股四头肌肌力评分、膝关节活动度测量。比较两组患者治疗后DOMS≤1级所需周数和患者的治疗-愈合时间(THT)。结果经治疗后患者均获得临床愈合。达到DOMS≤1级的时间:试验组为(12.21±1.62)周;对照组为(17.05±3.51)周,THT:试验组为(16.44±2.14)周;对照组为(20.20±2.19)周,试验组骨折DOMS≤1级的时间及愈合时间均优于对照组,差异有统计学意义(P<0.05)。结论体外冲击波对于应力性骨折的治疗在加速骨折愈合和缓解疼痛症状方面均明显优于传统治疗方法,并有效预防关节僵硬和肌力下降,疗效明确,具有确切的应用价值。

Therapeutic effects of extracorporeal shock waves for the treatment of tibia stress fractures

Objective To compare the effects of extracorporeal shock waves and conventional methods for the treatment of tibia stress fractures, and to observe the effectiveness and safety of extracorporeal shock wave therapy. Methods 34 male soldiers, diagnosed the tibia stress fractures, in our hospital from January 2011 to September 2012, were randomly divided into experimental group （19 cases） and the control group （15 cases）. The experimental group used extracorporeal shock wave treatment to treat fractures. Control group was used the plaster immobilization methods. After treatment, reviewed X-rays, CT, checked the general condition, and DOMS fatigue level 6 ratings, assessing the quadriceps muscle strength and measuring the angle of the knee joint activities every 4 weeks. Comparing two groups of patient＆#39;s time of recover to DOMS≤1, and patient＆#39;s treatment-healing-time （THT）. Results After treatment, all patients were clinically healed. The time of recover to DOMS≤1 level：the experimental group was （12.21 ±1.62） weeks;the control group was （17.05±3.51） weeks, the difference was statistically significant （P＆lt;0.05）. THT：the experimental group was （16.44±2.14） weeks;the control group was （20.20±2.19） weeks, the difference was statistically significant （P＆lt;0.05）. Conclusions Extracorporeal shock wave therapy for stress fractures was significantly better than conventional treatment methods which accelerating fracture healing and relieving the pain. It has clear therapeutic effective and the exact application value.